Nerve Growth Factor clinical trials
Also written NGF.
How each study uses Nerve Growth Factor is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Nerve Growth Factor studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
14 studies that test it; most in 2017 (3)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 2 |
| 2024 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 11
Aalborg University (4) · The Third Affiliated hospital of Zhejiang Chinese Medical University (3) · Dompé Farmaceutici S.p.A (1) · Jinling Hospital, China (1) · Prof Herta Flor (1) · Beijing Tiantan Hospital (1) · Shenyang Sunshine Pharmaceutical Co., LTD. (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Nerve Growth Factor is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 14
- Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer PainRecruitingPhase 1/2Shenyang Sunshine Pharmaceutical Co., LTD.NCT07008703Written as Injection of humanized nerve growth factor (NGF) antibody
- Effect of Specific Mode Electroacupuncture Stimulation Combined with NGF on Dysphagia After Ischaemic Stroke: a Pilot Randomized Controlled TrialRecruitingPhase 4The Third Affiliated hospital of Zhejiang Chinese Medical UniversityNCT06737549Written as Nerver growth factor (NGF) injection
- Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules in the Treatment of Amyotrophic Lateral SclerosisNot yet recruitingPhase 2/3Beijing Tiantan HospitalNCT06391645Written as Nerve Growth Factor
- The Impact of Electroacupuncture Combined With NGF on Clinical Effect and Functional Changes on Ischemic StrokeRecruitingPhase 4The Third Affiliated hospital of Zhejiang Chinese Medical UniversityNCT05231694Written as Nerver growth factor (NGF) injection
- Effect of EA Combined With NGF on Limb Function in Convalescent Patients With Ischemic StrokeStatus unknownNot applicableThe Third Affiliated hospital of Zhejiang Chinese Medical UniversityNCT05652751Written as nerve growth factor
- Efficacy and Safety of Nerve Growth Factor or Edaravone on Alcohol-induced Brain InjuryStatus unknownPhase 2Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNCT03968042Written as Nerve Growth Factor
- Exercise-induced Ischemia and the Influence of Pain Modulation in a Nerve Growth Factor (NGF) ModelStatus unknownEarly Phase 1Aalborg UniversityNCT03844243Written as NGF
- Interaction Between NGF and Acute Exercise-induced IschemiaCompletedEarly Phase 1Aalborg UniversityNCT03470038Written as NGF
- An 8-week Study to Evaluate Safety and Efficacy of NGF Eye Drops Solution Versus Vehicle in Patients With Dry EyeCompletedPhase 2Dompé Farmaceutici S.p.ANCT03019627Written as NGF
- Cortical Neuroplasticity by Muscle Pain of Pain-induced PlasticityCompletedNot applicableAalborg UniversityNCT03354624Written as Sterile solutions of recombinant human nerve growth factor (NGF)
- Spread of Muscle Hyperalgesia and Pain in a Low Dose NGF-induced Pain ModelCompletedEarly Phase 1Aalborg UniversityNCT03217942Written as NGF
- Effects of Intranasal Nerve Growth Factor for Traumatic Brain InjuryCompletedPhase 2Jinling Hospital, ChinaNCT01212679Written as nerve growth factor
- Cortical Representation of Hyperalgesia Induced by Nerve Growth FactorCompletedNot applicableProf Herta FlorNCT02159170Written as NGF injection
- Encapsulated Cell Biodelivery of Nerve Growth Factor to Alzheimer´s Disease PatientsStatus unknownPhase 1NsGene A/SNCT01163825Written as Nerve Growth Factor
Codes
What other systems call Nerve Growth Factor · ClinicalTrials.gg INT008784
- MeSH (NLM) D020932Nerve Growth FactorOne source Wikidata
- UNII (FDA) V7FWP1D62ONERVE GROWTH FACTORConfirmed FDA, Wikidata
- RxNorm 7327One source FDA
- Wikidata Q417782nerve growth factorConfirmed FDA, Wikidata
- NCI Thesaurus C684Recombinant Nerve Growth FactorOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D020932 | Nerve Growth Factor | One source Wikidata |
| UNII (FDA) | V7FWP1D62O | NERVE GROWTH FACTOR | Confirmed FDA, Wikidata |
| RxNorm | 7327 | — | One source FDA |
| Wikidata | Q417782 | nerve growth factor | Confirmed FDA, Wikidata |
| NCI Thesaurus | C684 | Recombinant Nerve Growth Factor | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.